Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Medical vs Non-medical Treatment for Metabolic Syndrome
NCT02503865Phase 2Completed
- Sponsor
- Nazarbayev University
- Start
- Jan 2003
- Primary completion
- Dec 2008
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in metabolic syndrome (3 arms), sponsored by Nazarbayev University. Primary endpoints: Blood Glucose Level at 12 weeks and Systolic/Diastolic Blood Pressures at 12 weeks. Started Jan 2003; status: completed.
02
Conditions
metabolic syndrome
Beyond the preview
Go deeper on NCT02503865.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02503865.